...
首页> 外文期刊>Critical reviews in oncology/hematology >Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets
【24h】

Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets

机译:转移性胰腺癌的治疗:当前的治疗选择和潜在的新治疗靶点

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic ductal adenocarcinoma is a malignancy with a poor prognosis, with the majority of patients diagnosed with advanced disease on presentation. Treatment options remain limited with little progress over the last 40 years. This review will focus on the current management of metastatic pancreatic ductal adenocarcinoma, with a discussion of new and future treatment strategies based on an improved understanding of tumour biology and mechanisms of pathogenesis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
机译:胰腺导管腺癌是一种预后较差的恶性肿瘤,大多数患者被诊断为晚期疾病。在过去的40年中,治疗方案仍然有限,进展甚微。这篇综述将集中于转移性胰腺导管腺癌的当前治疗,并基于对肿瘤生物学和发病机理的进一步了解,讨论新的和未来的治疗策略。 (C)2015 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号